Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2022 Results - Earnings Call Transcript

Call Start: 17:00 January 1, 0000 6:00 PM ET

Merit Medical Systems, Inc. (NASDAQ:MMSI)
Q2 2022 Earnings Conference Call
July 27, 2022 17:00 ET

Company Participants

Fred Lampropoulos - President & Chief Executive Officer
Brian Lloyd - Chief Legal Officer & Corporate Secretary
Raul Parra - Chief Financial Officer

Conference Call Participants

Jayson Bedford - Raymond James
Larry Biegelsen - Wells Fargo
Steve Lichtman - Oppenheimer & Company
Jim Sidoti - Sidoti & Company
Mike Matson - Needham & Company
William Plovanic - Canaccord Genuity
Joseph Downing - Piper Sandler

Operator

Please standby. Welcome to the Second Quarter of Fiscal Year 2022 Earnings Conference Call for Merit Medical Systems, Inc. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.

I would now like to turn the call over to Fred Lampropoulos, Merit Medical Systems' Founder, Chairman and Chief Executive Officer. Please go ahead, sir.

Fred Lampropoulos

Thank you and welcome, everyone, to Merit Medical's second quarter of fiscal year 2022 earnings conference call. I'm joined today with Raul Parra, our Chief Financial Officer and Treasurer; and Brian Lloyd, our Chief Legal Officer and Corporate Secretary. Brian, would you mind taking us through the Safe Harbor statements, please?

Brian Lloyd

Thank you, Fred.

I would like to remind everyone that this presentation contains forward-looking statements that receive Safe Harbor protection under federal securities laws. Although we believe these forward-looking statements are based upon reasonable assumptions, they are subject to unknown risks and uncertainties. The realization of any of these risks or uncertainties, as well as extraordinary events or transactions impacting our company, could cause actual results to differ materially from those currently anticipated. In addition, any forward-looking statements represent our views only as of today, July 27, 2022 and should not be relied upon